Literature DB >> 17109774

Low genetic diversity of the intrinsic OXA-51-like class D carbapenemases among Acinetobacter baumannii clinical isolates in Greece.

A Ikonomidis1, S Pournaras, A Markogiannakis, A N Maniatis, E N Manolis, A Tsakris.   

Abstract

This study examined the geographical distribution and diversity of the intrinsic OXA-51-like class D carbapenemases among Acinetobacter baumannii clones recovered in three major Greek regions from 2000 to 2005. The blaOXA-66 allele was exclusively detected among clonally distinct A. baumannii isolates recovered in the regions of Thessaloniki and Larissa. This sequence was also the most widespread among A. baumannii isolates in Athens, while less frequent were blaOXA-69 and blaOXA-65 alleles. These findings highlight the high prevalence of a specific blaOXA-51-like allele in Greece, possibly indicating that our A. baumannii clones might have originated from a common ancestor. However, the possibility that blaOXA-51-like variants, with blaOXA-66 predominating, are widely disseminated among several unrelated A. baumannii strains cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109774      PMCID: PMC2870635          DOI: 10.1017/S0950268806007527

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  19 in total

1.  The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.

Authors:  Jane F Turton; M Elaina Ward; Neil Woodford; Mary E Kaufmann; Rachel Pike; David M Livermore; Tyrone L Pitt
Journal:  FEMS Microbiol Lett       Date:  2006-05       Impact factor: 2.742

2.  High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres.

Authors:  Haluk Vahaboglu; Fatma Budak; Murat Kasap; Gulcin Gacar; Sinem Torol; Aynur Karadenizli; Fetiye Kolayli; Cafer Eroglu
Journal:  J Antimicrob Chemother       Date:  2006-07-01       Impact factor: 5.790

Review 3.  OXA-type carbapenemases.

Authors:  Jan Walther-Rasmussen; Niels Høiby
Journal:  J Antimicrob Chemother       Date:  2006-01-30       Impact factor: 5.790

Review 4.  Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.

Authors:  John E McGowan
Journal:  Am J Infect Control       Date:  2006-06       Impact factor: 2.918

5.  Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species.

Authors:  Jane F Turton; Neil Woodford; Judith Glover; Susannah Yarde; Mary E Kaufmann; Tyrone L Pitt
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

6.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Authors:  Neil Woodford; Matthew J Ellington; Juliana M Coelho; Jane F Turton; M Elaina Ward; Susan Brown; Sebastian G B Amyes; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2006-03-24       Impact factor: 5.283

Review 7.  The impact of carbapenemases on antimicrobial development and therapy.

Authors:  David M Livermore
Journal:  Curr Opin Investig Drugs       Date:  2002-02

8.  bla(OXA-51)-type beta-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii.

Authors:  Andrea Karina Merkier; Daniela Centrón
Journal:  Int J Antimicrob Agents       Date:  2006-07-17       Impact factor: 5.283

9.  Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-beta-lactamase.

Authors:  Eun-Jee Oh; Seungok Lee; Yeon-Joon Park; Jung Jun Park; Kanggyun Park; Sang-Il Kim; Moon Won Kang; Byung Kee Kim
Journal:  J Microbiol Methods       Date:  2003-09       Impact factor: 2.363

10.  VIM-1 metallo-beta-lactamase in Acinetobacter baumannii.

Authors:  Athanassios Tsakris; Alexandros Ikonomidis; Spyros Pournaras; Leonidas S Tzouvelekis; Danai Sofianou; Nicholas J Legakis; Antonios N Maniatis
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

View more
  1 in total

1.  Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii.

Authors:  Alexandros Ikonomidis; Evangelia Neou; Vassiliki Gogou; Georgia Vrioni; Athanassios Tsakris; Spyros Pournaras
Journal:  J Clin Microbiol       Date:  2009-10-14       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.